Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

TGF-β1 (human), (recombinant)

 
ENZ-PRT221-0020 20 µg 650.00 USD
Do you need bulk/larger quantities?
 

Product Specification

Alternative Name:Differentiation inhibiting factor, Cartilage-inducing factor, Transforming growth factor β1
 
MW:Dimer ~12.8/25.6 kDa
 
Source:Produced in CHO cells. Contains 112/224 amino acids.
 
UniProt ID:P01137
 
Formulation:Lyophilized. Contains 0.1% trifluoroacetic acid and trehalose (in a 20:1 trehalose to protein ratio).
 
Purity:≥95% (SDS-PAGE)
 
Endotoxin Content:≤1 EU/µg protein (LAL test)
 
Reconstitution:Reconstitute in sterile 10 mM HCl at 0.1 mg/mL.
 
Shipping:Ambient
 
Short Term Storage:+4°C
 
Long Term Storage:-80°C
 
Handling:Avoid freeze/thaw cycles. After reconstitution, prepare aliquots and store at -80°C. For long term storage, it is recommended to dilute to working aliquots in a 0.1% BSA solution.
 
Scientific Background:Transforming growth factor β1 (TGF-β1) is a member of the TGF-β superfamily of cytokines. Members of this family exhibit regulatory activity in immunity, proliferation, adhesion, migration, and growth inhibition pathways. TGF-β1 signals through SMAD proteins via the TGF-βRI and TGF-βRII receptors.
 

Product Toolbox

PRODUCT RESOURCES

Datasheet
MSDS
Certificate of Analysis

RELATED PRODUCTS

By target:
TGF-beta
By biological activity:
TGF-beta Recombinant protein
By catalog section:

PRODUCT SUPPORT

FAQs
Technical Service
Customer Service

Recommend this page

 
For Research Use Only. Not for use in diagnostic procedures.
Keep in touch

©2017 Enzo Life Sciences, Inc.,